IL2 and autoimmune gastritis: The short-term neutralization of circulating IL-2 by anti-IL-2 monoclonal antibody reduces the number of Tregs in the periphery and elicits autoimmune gastritis in BALB/c mice and diabetes and other autoimmune manifestations in non-obese diabetic (NOD) mice [37].